Dr. Burger is the principal of Advanced Cell & Gene Therapy, a consulting firm specializing in cell, gene, and tissue-based therapies. Dr. Burger works with clients in industry and academic centers worldwide, providing assistance in process development and validation, GMP/GTP manufacturing, GMP facility design and operation, regulatory affairs, technology evaluation, and strategic analysis. He received his M.D. from the University of Pennsylvania School of Medicine, and completed postgraduate training in Laboratory Medicine, as well as a clinical fellowship in Transfusion Medicine and a postdoctoral research fellowship, at Washington University in St. Louis. Dr. Burger served as medical director of the Cell Therapy Clinical Laboratory and Molecular and Cellular Therapeutics Facility at University of Minnesota, where he was responsible for process development, validation, and GMP production of a broad range of novel cell and gene therapies, in support of over 75 clinical trials. Dr. Burger also was Vice-President for Research and Development at Merix Bioscience, a biotechnology company focused on dendritic cell immunotherapy. He serves on the USP Cell, Gene and Tissue Therapies Expert Committee, the advisory boards of several cell therapy biotechnology companies, and has served as editor of the International Society for Cellular Therapy Telegraft, and on the ISCT Executive Committee. A frequently invited speaker at industry and academic conferences, he is the author of over 100 scientific publications and presentations, and recipient of numerous honors and awards.